Democratizing
Brain
Health
Our Mission
To democratize brain health by making cognitive care as accessible, intuitive, and universal as messaging.
We’re reimagining how people engage with their minds—turning everyday communication into a vehicle for emotional connection, memory support, and cognitive wellbeing.
The Science Behind What We Build
At Kompanion, our work is grounded in decades of interdisciplinary neuroscience, clinical psychology, and digital health innovation. We combine validated cognitive therapies with the latest advancements in generative AI to deliver structured, personalized wellness sessions that are both accessible and therapeutically meaningful.
Grounded in Proven Brain Health Practices
At Kompanion, we are translating decades of established brain wellness methods into a new kind of daily support. Drawing from therapies like reminiscence, cognitive stimulation, and behavioral activation, we transform everyday moments—like a voice message or a shared photo—into structured, emotionally engaging micro-sessions. These experiences are designed to preserve attention, spark joy, and reinforce connection, particularly for individuals at risk of cognitive or emotional decline.
Engineered with Human-Centered AI
We're building our platform using a blend of clinical insight and generative AI. Each interaction is modeled on validated therapeutic formats, then adapted in real time to the user’s pace, tone, and preferences. Through voice and visual cues, Lilia crafts guided sessions that feel familiar and warm—not clinical or scripted. Our goal is to deliver meaningful cognitive care using the most intuitive tools people already know: their phone and their voice.
An Artificial
Intelligence
Companion
Designed for Impact, Built for Scale
Every Lilia session contributes to a deeper understanding of a user’s emotional and cognitive journey. We're developing feedback loops that capture patterns in engagement and mood—enabling personalized care while generating insights for families and professionals. This is our long-term vision: to make brain health support continuous, conversational, and deeply human—accessible to anyone, anywhere, with no training required.
The Reasons Behind Developing Lilia:
I.
II.
III.
IV.
V.
A very large number of people are affected by dementia and too few neurologists to take care of them
2,980 neurologists must take care of more than one million patients in France, with 220,000 new cases per year.
The Importance of Cognitive Therapies in Disease Progression
To date, non-pharmaceutical therapies based on cognitive stimulation have demonstrated an improvement in cognitive functions and patient quality of life comparable to pharmacological approaches (*). It is interesting to note that cognitive stimulation is the only non-pharmacological intervention recommended by the UK's National Institute for Clinical and Health Excellence for people with dementia.
* Reference: Spector A. Thorgrimsen L. Woods B.O.B. Royan L. Davies S. Butterworth M. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomized controlled trial. Br J Psychiatry. 2003;183:248–254
The Need for a Personalised Approach
Two main directions must be taken into account in cognitive therapy:
-
Individual and/or group sessions with the patient on themes and situations that will allow them to use the language acts they can still emit correctly: the more these acts are used by the patient, the longer they will remain within their competence.
-
Taking into account and adapting the environment (caregivers, assistants, family, etc.) to the changes in the patient's communication capacities.
Taking into account the Isolation Factor of Patients in the Evolution of the Disease.
Isolation is a cause and a symptom.
The Difficulty of Making Cognitive Therapy Accessible to All Patients
Studies show that cognitive therapies are both effective and cost-effective, but their current availability is limited and access is reserved for a minority.*
*Knapp M, Bauer A, Wittenberg R, et al. What are the current and projected future cost and health-related quality of life implications of scaling up cognitive stimulation therapy? Int J Geriatr Psychiatry. 2021;1‐10. doi:10.1002/gps.5633
The stakes of the research and projects led by
New patient monitoring tools need to be developed to allow practitioners to follow a larger number of patients while maintaining the quality of their care.
Several scientific studies have also established a link between the lack of cognitive stimulation and an earlier onset of the first signs of dementia: these studies show that cognitive stimulations delay the first signs of dementia disease by an average of five years.
Cognitive stimulation thus constitutes a major challenge for prevention but also for slowing down the progression of the disease.
The development of Lilia takes into account these two dimensions in the construction of interactions with the patient: Lilia will constantly seek to modulate its communication behavior to adapt to that of the patient.
Isolation is both a cause and a symptom of dementia disease, increasing the risk of depression, anxiety, and violent behaviors. Lilia could help reduce patients' feeling of isolation by:
-
Helping patients feel less alone and neglected in managing the disease and side effects related to potential treatments.
-
Interacting regularly with the patient and encouraging them to communicate with their loved ones.
Kompanion Care is to determine to what extent recent advances in digital technologies can democratise patients' access to cognitive therapies:
-
Due to their reduced cost
-
The acceptability of patients to receive cognitive therapy in a semi-autonomous manner